Distalmotion wins FDA de novo nod for Dexter surgical robot

Distalmotion announced today that it received FDA de novo approval for its Dexter surgical robot for adult inguinal hernia repair.

Lausanne, Switzerland–based Distalmotion can now bring Dexter to the U.S. with more than 1,300 patients already treated in Europe.

The company designed Dexter to deliver robotics’ benefits to more hospitals, outpatient departments and ambulatory surgical centers (ASCs). As a modular, small-format, open system, it offers simplicity and straightforwardness, plus more accessibility, according to the company.

Distalmotion said Dexter can work natively with third-party 3D imaging systems, energy devices, vessel sealers and other laparoscopic devices. It features a suite of fully wristed, single-use instruments. These deliver dexterity, precision of movement, reliable instrument performance and lower reprocessing requirements.

Sign up for Blog Updates